Company Name | Ucb Pharmaceuticals |
---|---|
Website | https://www.ucb.com |
Snippet | UCB is a global biopharmaceutical company focused on creating value for people living with severe diseases in immunology and neurology. We work with stakeholders to address the unmet needs of patients and caregivers, helping them to achieve their goals and to live the lives they want. |
Type | Société anonyme |
Founded | 1928 |
Revenue | € 4.632 billion (2018)[1] |
Website | www.ucb.com |
Industry | Pharmaceuticals |
Products | Biopharmaceuticals |
Traded as | Euronext: UCBBEL 20 component |
Key people | Gerhard Mayr (Chairman), Jean Christophe Tellier (CEO) |
Net income | € 0.823 billion (2018)[1] |
Headquarters | Brussels, Belgium |
Operating income | € 1.109 billion (2018)[1] |
Number of employees | 7,489 (end 2018)[1] |
Ucb Pharmaceuticals is part of the Belgium company list
Ucb Pharmaceuticals is part of the Pharmaceuticals company list
Have a list of company names and need to update information? Use our Company Search tool.
Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.
Want to update this profile? Please contact us here with a link to the public source verifying the edit.
Powrbot Inc. is a passionate company working on problems using data analytics, automation & machine learning. Our goal is to automate the boring stuff.
Contact Us